ArticleJournal of clinical medicine2024

The Real-World Effectiveness, Persistence, Adherence, and Safety of Janus Kinase Inhibitor Baricitinib in Rheumatoid Arthritis: A Long-Term Study.

Alberto Calvo-Garcia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.